<DOC>
	<DOCNO>NCT02122705</DOCNO>
	<brief_summary>This study prospective case series aim evaluate new VPIA remifentanil algorithm would benefit labour mother unable unwilling receive epidural analgesia .</brief_summary>
	<brief_title>A Case Series VPIA Using Remifentanil Labour Delivery</brief_title>
	<detailed_description>This study propose novel Vital signs-controlled , patient-assisted intravenous analgesia ( VPIA ) regimen enhance efficacy , safety personalization remifentanil therapy labour woman . This system study parturient 's pattern analgesic use 15 min epoch titrate demand dose basal infusion rate maintain plasma level remifentanil appropriate degree pain felt . The system incorporate vital sign ( pulse oximetry heart rate value ) algorithm would temporarily stop pump step dos accordingly predefined critical value reach .</detailed_description>
	<mesh_term>Labor Pain</mesh_term>
	<mesh_term>Remifentanil</mesh_term>
	<criteria>Patients choose use parenteral opioid pain relief inform consent Patients refuse labour epidural analgesia Patients contraindication epidural analgesia ( eg . Thrombocytopaenia , previous thoracolumbar spinal instrumentation ) Patients unable understand instruction give regard use patient control analgesia ( PCA ) unable self administer PCA boluses Patients difficulty communication due language difference Patients know hypersensitivity remifentanil component formulation fentanyl analog Patients severe respiratory disease Patients history drug dependence recreational drug abuse Patients unmanaged foetal bradycardia</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Remifentanil</keyword>
	<keyword>Labour analgesia</keyword>
</DOC>